Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05TMN
|
|||
| Drug Name |
PMID25514969-Compound-8
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
Takeda Pharmaceutical Co. Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H13F3N4O2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)CNC(=O)C2=CN=C3N2C=C(C=C3C4=CN=CO4)C(F)(F)F
|
|||
| InChI |
1S/C19H13F3N4O2/c20-19(21,22)13-6-14(16-9-23-11-28-16)17-24-8-15(26(17)10-13)18(27)25-7-12-4-2-1-3-5-12/h1-6,8-11H,7H2,(H,25,27)
|
|||
| InChIKey |
PSHYVANCPSFWJM-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cholesterol 24-hydroxylase (CYP46A1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Cholesterol 24-hydroxylase (CYP46A1) | Target's Patent Info | [1] | |
| KEGG Pathway | Primary bile acid biosynthesis | |||
| Pathwhiz Pathway | Bile Acid Biosynthesis | |||
| Reactome | Endogenous sterols | |||
| WikiPathways | Metapathway biotransformation | |||
| Oxidation by Cytochrome P450 | ||||
| Phase 1 - Functionalization of compounds | ||||
| Bile acid and bile salt metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Imidazo[1,2-a]pyridines as cholesterol 24-hydroxylase (CYP46A1) inhibitors: a patent evaluation (WO2014061676).Expert Opin Ther Pat. 2015 Mar;25(3):373-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.